Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review for the US Preventive Services Task Force

@article{Williams2009ScreeningFC,
  title={Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review for the US Preventive Services Task Force},
  author={Selvi B. Williams and Elizabeth A. O’Connor and Michelle Eder and Evelyn P. Whitlock},
  journal={Pediatrics},
  year={2009},
  volume={123},
  pages={e716 - e735}
}
CONTEXT. Depression among youth is a disabling condition that is associated with serious long-term morbidities and suicide. OBJECTIVE. To assess the health effects of routine primary care screening for major depressive disorder among children and adolescents aged 7 to 18 years. METHODS. Medline, the Cochrane Central Registry of Controlled Trials, PsycInfo, the Cochrane Database of Systematic Reviews, recent systematic reviews, experts, and bibliographies from selected studies were the data… 

Figures and Tables from this paper

Depression screening and mental health outcomes in children and adolescents: a systematic review protocol
TLDR
The proposed systematic review will determine whether there is sufficient evidence of benefits in excess of harms and costs to support screening for depression in childhood and adolescence.
Depression Screening and Health Outcomes in Children and Adolescents: A Systematic Review
TLDR
There is no direct RCT evidence that supports depression screening among children and adolescents, and groups that consider recommending screening should carefully consider potential harms, as well as the use of scarce health resources, that would occur with the implementation of screening programs.
Accuracy of Depression Screening Tools to Detect Major Depression in Children and Adolescents: A Systematic Review
TLDR
There is insufficient evidence that any depression screening tool and cut-off accurately screens for MDD in children and adolescents, which could lead to overdiagnosis and the consumption of scarce health care resources.
Screening and Treatment for Major Depressive Disorder in Children and Adolescents: US Preventive Services Task Force Recommendation Statement
TLDR
Evidence is insufficient to warrant a recommendation to screen children for major depressive disorder, and systems are in place to ensure accurate diagnosis, psychotherapy (cognitive-behavioral or interpersonal), and follow-up (B recommendation).
Managing and preventing depression in adolescents
TLDR
This review provides guidance for non-specialists on the assessment and management of adolescent unipolar depression and considers emerging evidence on prevention strategies.
Improving validated depression screen among adolescent population in primary care practice using electronic health records (EHR).
TLDR
After 12 months of implementing this project with four PDSA cycles, the adolescent depression-screening rate improved from 10-15% from the previous two years to 65% (six month period) and 82% at the end of the 12 month period.
Does screening for and intervening with multiple health compromising behaviours and mental health disorders amongst young people attending primary care improve health outcomes? A systematic review
TLDR
There is some evidence that the use of screening and intervention with young people for mental health disorder or health compromising behaviours in clinical settings improves health outcomes.
Screening for Major Depressive Disorder in Children and Adolescents: A Systematic Review for the U.S. Preventive Services Task Force
TLDR
The objective of this report is to update the recommendations released in 2009 for screening adolescents and children for MDD in primary care and similar settings (such as school-based clinics) and to determine whether the benefits and harms differed by age, sex, or race/ethnicity.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 123 REFERENCES
Improving recognition of adolescent depression in primary care.
OBJECTIVE To address the following questions: (1) What evidence (ie, psychometric data collected in pediatric primary care, patient outcome data) exists for the various methods used to identify
Screening for depression across the lifespan: a review of measures for use in primary care settings.
TLDR
Targeted screening in high-risk patients such as those with chronic diseases, pain, unexplained symptoms, stressful home environments, or social isolation, and those who are postnatal or elderly may provide an alternative approach to identifying patients with depression.
Interventions for Adolescent Depression in Primary Care
TLDR
There is potential for successful treatment of adolescent depression in primary care, in view of evidence that brief, psychosocial support, with or without medication, has been shown to improve a range of outcomes, including adolescent depression itself.
Screening for Depression: Recommendations and Rationale
  • A. Berg
  • Psychology, Medicine
    Annals of Internal Medicine
  • 2002
TLDR
There is little evidence to recommend one screening method over another, so clinicians can choose the method that best fits their personal preference, the patient population served, and the practice setting.
A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents.
TLDR
Adolescents treated with IPT-A compared with TAU showed greater symptom reduction and improvement in overall functioning, a significant step toward closing the gap between treatment conducted in the laboratory and community clinic.
Is there an epidemic of child or adolescent depression?
TLDR
There is no evidence for an increased prevalence of child or adolescent depression over the past 30 years when concurrent assessment rather than retrospective recall is used and public perception of an 'epidemic' may arise from heightened awareness of a disorder that was long under-diagnosed by clinicians.
Review of the efficacy and safety of antidepressants in youth depression.
TLDR
Clinicians need to be judicious in their interpretation of research data on pediatric antidepressant trials because of the variability in trial methodology and the variation in the drug/placebo response rates within a single trial.
The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
TLDR
In adolescents with moderate to severe depression, treatment with fluoxetine alone or in combination with CBT accelerates the response and combined treatment appears superior to either monotherapy as a treatment for major depression in adolescents.
Screening and early psychological intervention for depression in schools
TLDR
Although the number of studies is small and their quality is limited, screening and early intervention at schools may be an effective strategy to reduce the burden of disease from depression in children and adolescents.
...
1
2
3
4
5
...